Rokajax search

Monday, 27th June 2022



  • Home
  • Lopez Companies
    • Business and Finance
    • Calendar
    • Promos and Offers
    • Lopez Group Companies
  • HR Updates
    • HR Council
    • Business Excellence
    • Job Opportunities
  • Employee News
    • Message from Lopez
    • Meet the Executive
    • Meet the Team
    • Milestones
    • Spotlight
    • Advocacy
  • Corporate Sustainability
    • ABS-CBN Foundation
    • Sagip Kapamilya
    • OML Climate Change Center
    • Knowledge Channel
    • Lopez Museum
  • Lifestyle
    • Kapamilya Entertainment
    • Power Plant Mall Finds
    • ABS-CBN Publications
    • Food and Recipes
    • Lifelong Wellness
  • Blog
  • Lopez Values
    • 7 Lopez Values
    • The Credo
    • Web Comics
    • Special Feature

All about the vaxx

Twitter

All about the vaxxAll about the vaxxHeres a quick look at the main vaccine brands being used in Vac2Normal and in the Kapamilya Vaccination Program: AstraZeneca, Moderna and Novavax’s Covovax.

OXFORD ASTRAZENECA

Manufacturer/developer: AstraZeneca, University of Oxford (UK)

Countries with EUA: 99 countries including US, UK, Australia, Mexico, Argentina, India, Philippines

Philippine FDA EUA approval: January 28, 2021

Age group covered by FDA EUA approval: 18 years old and above

Technology platform: Viral vector (nonreplicating)

Dose and frequency: 2 doses, 4-12 weeks apart

Vaccine efficacy (VE): 70.4% overall VE against symptomatic COVID-19, 14 days after the second dose

Common adverse events reported in Phase III clinical trials: Injection site pain and tenderness, fatigue, headache, feverishness, myalgia (muscle pain)

Serious adverse events reported in Phase III clinical trials: None reported

 

MODERNA

Manufacturer/developer: Moderna, National Institute of Allergy and Infectious Diseases (US)

Countries with EUA: 49 countries with EUA approval including US, UK, EU, Switzerland, Canada, Australia, Philippines

Philippine FDA EUA approval: May 5, 2021

Age group covered by FDA EUA approval: 18 years old and above

Technology platform: mRNA

Dose and frequency: 2 doses, 28 days apart

Vaccine efficacy (VE): 94.1% overall VE against symptomatic COVID-19, occurring at least 14 days after the second dose; 100% VE against severe COVID-19

Common adverse events reported in Phase III clinical trials: Injection site pain, fatigue, headache myalgia (muscle pain), arthralgia (joint pain), chills, nausea/vomiting, axillary swelling/tenderness, fever, swelling at the injection site and erythema (skin redness/inflammation) at the injection site

Serious adverse events reported in Phase III clinical trials: Severe allergic reactions, including anaphylaxis

 

COVOVAX

Manufacturer/developer: Serum Institute of India, Novavax (US)

Countries with EUA: No EUA approvals yet

Philippine FDA EUA approval: --

Age group covered by FDA EUA approval: --

Technology platform: Protein subunit

Dose and frequency: 2 doses, 21 days apart

Vaccine efficacy (VE): Awaiting EUA application

Common adverse events reported in Phase III clinical trials: Awaiting EUA application

Serious adverse events reported in Phase III clinical trials: Awaiting EUA application (Source: doh.gov.ph)

 

More Articles from Lopezlink

‘Sino Ang Maysala?’ set to reveal real culprit

‘Sino Ang Maysala?’ set to reveal real culprit

Asian Eye earns platinum recognition from Accreditation Canada

Asian Eye earns platinum recognition from Accreditation Canada

Love Me Tomorrow on Super KBO, SKY PPV

Love Me Tomorrow on Super KBO, SKY PPV

EDC powers Mondelez plant with geothermal energy

EDC powers Mondelez plant with geothermal energy

Fresh SKY plans bundle unli broadband with WiFi solutions

Fresh SKY plans bundle unli broadband with WiFi solutions

Meet the Team of Studio XP

Meet the Team of Studio XP

SKY completes digitalization of internet, cable in Zambo

SKY completes digitalization of internet, cable in Zambo

Dicky Liwanag: Telco exec finds his ‘WHY’ in SKY

Dicky Liwanag: Telco exec finds his ‘WHY’ in SKY

MAGBU celebrates workplace safety day

MAGBU celebrates workplace safety day

Virtual corporate governance training

Virtual corporate governance training

Blockbusters, Oscar winners on Movie Central

Blockbusters, Oscar winners on Movie Central

Kuya names new set of teen housemates in ‘Pinoy Big Brother Otso’

Kuya names new set of teen housemates in ‘Pinoy Big Brother Otso’

EDC’s P5B ASEAN Green Bond is best local currency green bond

EDC’s P5B ASEAN Green Bond is best local currency green bond

Cedie Lopez-Vargas: The voice of the Lopez values

Cedie Lopez-Vargas: The voice of the Lopez values

COVID-19 in PH

ABS-CBN Lingkod Kapamilya Foundation

Subscribe to Lopezlink

Lopez Holdings Corp. All rights reserved



About Us | Copyright | Sitemap | Archive